ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0231

Primary Care Physician’s Perspective and Needs on Early Rheumatoid Arthritis Diagnosis: REUCARE Program for Early Referral

Camille Bourgeois1, Jorge Olmedo Galindo2, Juan Molina1, Gema Fernandez-Plana2, Julia Martinez-Barrio1, Javier Rivera3 and Isabel Castrejon4, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Gerencia Asistencial Atención Primaria, Comunidad de Madrid, Madrid, Spain, 3Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 4Hospital Universitario Gregorio Marañón, Madrid, Spain

Meeting: ACR Convergence 2022

Keywords: Epidemiology, Outcome measures, primary care, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Primary care physicians (PCPs) play a crucial role in early recognition and rapid referral of patients with inflammatory arthritis to improve early management and patient outcomes. However, there is limited information on perceived barriers for referral and areas of improvement (1). The purpose of this study is to explore the perspective and needs of PCPs to guide a specialist’s referral program.

Methods: A PCPs-rheumatology early referral program (REUCARE) has been initiated at our area in January 2022 with 257 PCPs participating. Up to May 2022, 88 patients have been referred, however only 24 (27%) fulfill inclusion criteria. In order to improve the referral strategy, a survey has been developed in collaboration with primary care investigators to explore areas of improvement. The survey included 5 domains covering: PCPs demographics, previous knowledge about RA, level of confidence, factors and potential barriers influencing referral and interest on rheumatological training. Data were captured using four-point Likert scales, yes/no question or free text, and were analyzed descriptively.

Results: E-mail invitations were sent to 257 PCPs through their primary care center coordinator and completed by 26 (10% response rate). More respondents were women (76%) in practice for over more than 20 years who reported having 30-40 patients per day and only 1-5 patients diagnosed of RA in the last year. The majority (83%) reported additional rheumatological training besides medical school, however they were no familiar with the incidence and prevalence of the disease. Around 67% were aware of the importance of early diagnosis and treatment, however they felt not very confident making the initial diagnostic (61% “somehow confident” and 35% “not confident”). Main reasons for referral were clinical presentation (65%), positive rheumatoid factor (46%) and elevation of acute phase reactants (46%). Most PCPs considered the waiting time for rheumatology prolonged (65%) and very prolonged (22%) and reported insufficient feedback information from rheumatologists (60%). Main reasons for delay from PCPs perspective were nonspecific initial symptoms of the disease (48%) followed by rheumatology long waiting list (39%) (Figure 1). Although 77% indicated using additional resources to improve their knowledge in RA, all participants stated that they would be interested in receiving more information on early diagnosis, being the preferred resources a specific e-consult (87%), updated mini guidelines (78%) and face-to face meetings with rheumatologists (Figure 2).

Conclusion: Most PCPs are aware of the importance of early diagnosis and management of RA but feel uncomfortable making the initial diagnosis. Non-specific initial symptoms and long waiting lists for rheumatology are the main reasons for delay from PCPs perspective. Resources to improve referral, including e-consult and specific guidelines, are in need as part of the actual referral program.

Supporting image 1

Figure 1: Causes of referral delays

Supporting image 2

Figure 2: Preferred source of information


Disclosures: C. Bourgeois, None; J. Olmedo Galindo, None; J. Molina, None; G. Fernandez-Plana, None; J. Martinez-Barrio, None; J. Rivera, None; I. Castrejon, None.

To cite this abstract in AMA style:

Bourgeois C, Olmedo Galindo J, Molina J, Fernandez-Plana G, Martinez-Barrio J, Rivera J, Castrejon I. Primary Care Physician’s Perspective and Needs on Early Rheumatoid Arthritis Diagnosis: REUCARE Program for Early Referral [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/primary-care-physicians-perspective-and-needs-on-early-rheumatoid-arthritis-diagnosis-reucare-program-for-early-referral/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-care-physicians-perspective-and-needs-on-early-rheumatoid-arthritis-diagnosis-reucare-program-for-early-referral/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology